| (Values in U.S. Thousands) | Dec, 2021 | Dec, 2020 | Dec, 2019 | Dec, 2018 | Dec, 2017 |
| Sales | 1,390 | 1,380 | 1,550 | 1,560 | 1,080 |
| Sales Growth | +0.72% | -10.97% | -0.64% | +44.44% | +74.19% |
| Net Income | -9,090 | -12,680 | -18,070 | -7,770 | -3,460 |
| Net Income Growth | +28.31% | +29.83% | -132.56% | -124.57% | -5,866.67% |
Avalon Globocare (AVCO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Avalon GloboCare Corp. outsourced healthcare services. It serves healthcare institutions, individual patients, academia and corporations sector. The company provides healthcare management which comprises cell-based technologies and therapeutics, genomic diagnostics and precision medicine, international health and telemedicine. It operates primarily in China and United States of America. Avalon GloboCare Corp is headquatered in Freehold, New Jersey.